While multiple studies have confirmed that TAVR and surgery are associated with comparable outcomes, it is important to take an individualized approach to all treatment decisions.

According to the FDA, a total of 10 people have been hospitalized due to symptoms associated with these products. They are marketed as a "leading form of microdosing."

The new surgical valve from Foldax was designed to limit calcification and make it so patients do not require long-term anticoagulant therapy following treatment. 

Healthcare's ongoing shift toward value-based care is a good thing, Joynt Maddox explained, but its implementation has been far from ideal. She also discussed population health, the pandemic, health disparities and the rising influence of private equity investments.

While one of the new devices was developed for the general public, the second was specifically designed for users with type 2 diabetes who do not take insulin.

Connolly spent 40 years at McMaster University as a professor and researcher, founding the school’s cardiac arrhythmia service line and serving as its cardiology chair. He remained active in electrophysiology research until the end of his life.

Paul Zei, MD, discusses late-breaking data from the REAL-AF Registry, which looked at the short- and long-term outcomes of radiofrequency ablation in paroxysmal and persistent atrial fibrillation.

Medtronic’s TAVR technology received a significant amount of attention during the very first New York Valves conference in New York City. Research focused on patients with small annuli as well as how five-year outcomes compare to surgery.